Researchers repurpose immune-activating cytokine to fight breast cancer

The most lethal form of breast cancer could have a new treatment option, according to new research. Researchers showed triple-negative breast cancer cells are highly vulnerable to interferon-? -- a potent antimicrobial that also activates the immune system. The new study shows interferon-? impairs breast cancer cells' ability to migrate and form tumors. The study also suggests interferon-? treatment could improve outcomes for certain breast cancer patients.